Amir Mehdizadeh-Shrifi,MD

Physician Resident MD @MedStarHealth | Thoracic and Transplant Oncology research MHHGermany | Former Research fellow @CincyKidsHeart | @FCBayern fan 🇺🇸🇩🇪

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

We are grateful to @accpchest for accepting 3/3 abstracts from our US-German collaboration on ICI-related pulmonary hypertension in lung cancer. Excited to highlight findings from one of the largest lung cancer pembrolizumab cohorts in Germany!

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

Excited and grateful to present 3/3 abstracts at this year’s ESMO meeting. Thank you to @myESMO for highlighting our work on longitudinal quality-of-life outcomes in patients with NSCLC treated with ICI
Grateful to Heiko Golpon and Felix Lennartz from Hannover Medical School and the German Lung Center for their collaboration and support.
See you in Madrid! #ESMO #LungCancer #Immunotherapy #QualityOfLife

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

Grateful & excited that @accpchest has selected our German–US oncology collaboration on cardiovascular findings during pembrolizumab therapy for a podium presentation. We highlight the unique cardiovascular challenges during the ICI-lung cancer journey. #lungcancer #oncology

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

Excited for our lab and brilliant colleague Dr. Felix Lennartz to put emphasis on lung cancer after lung transplantation @ISHLT
Grateful for @ISHLT and @ISHLTPres to shed light on the oncologic burden post -transplant!

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

We are deeply grateful for the @atscommunity accepting our abstracts on the challenges of synchronous lung cancer and supporting thoracic oncology/MPLC research. Excited to reunite with the lung cancer community and present our US-German collaborations.

[Nir Uriel, MD MSc @NirUrielMD]

What happens when we transplant cancer survivor patients ?

Cancer survivors are 4 times more likely to develop de novo malignancy post transplant, however, despite that their survival is comparable to contemporary survival of heart transplant patients.
More by Dr Raikhelkar

[The ISHLT @ISHLT]

#ISHLT2026 is just around the corner. ✈️ Start planning your travel to Toronto and book your hotel at the exclusive ISHLT attendee rate before reservations fill up. 🔗 https://t.co/fhutAEBIQt

[The ISHLT @ISHLT]

Happy New Year! 🎆 #ISHLT looks forward to an exciting 2026. Thank you for being a part of the global, multidisciplinary ISHLT community. 🎉

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

Thank you so much to the @ISHLT for the opportunity to present our new work on "Lung Cancer After Lung Transplantation" and our take on vigilant post-transplant lung cancer surveillance! We are excited to shed light this critical lung transplant population!

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

@LorenzoBragh @CCFcards @CleClinicHVTI @venumenon10 @DrRohitMoudgil Congratulations my friend , well deserved for a future leader in the field!

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

@LiamKugler @FloridaBlueKey @AAMCtoday @UFMedicine Congrats mate, keep it going !

[Gregg W. Stone MD @GreggWStone]

2025 US guidelines for the management of ACS (STEMI and NSTE-ACS) just released. Insertion of a
microaxial flow pump (Impella) to prevent death in in cardiogenic shock has received a class IIa LOE B-R recommendation. IABP and VA-ECMO are class III for rourine use.

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

@TulioCorrea @nunesbrunop Congrats on this interesting and important work !

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

@LorenzoBragh @MichaelFaulx @CCFcards Excited to seen your technical videos and growth ! Future leader !!!

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

@leelamorena @NEJM @MGHSurgery @mgh_transplant @LVRiella Congratulation on this groundbreaking work

[Anurag Sahu @achdDoc12]

There are more adults with #CHD than children with CHD by a ratio of 2:1. Lifelong care is esp for high quality outcomes.

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

@ralogon Thank you @ralogon for highlighting our paper and center outcomes. Thank you to @spencerjhogue for ongoing efforts to improve the Fontan population!

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

It is an absolute honor to be nominated as a Philip K. Caves Award finalist by @ISHLT We are grateful that @ISHLT is making mental health in lung transplantation visible. This would not be possible without the great mentorship of Morales Lab and great team at @CincyKidsHeart !

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

@Hosam_F_Ahmed @CincyChildrens @CincyKidsHeart @AnnalsATS Congratulations :)

[Amir Mehdizadeh-Shrifi,MD @AmirMehdSh]

Great results for @CincyKidsHeart & Morales lab. We will be presenting over 8 oral presentations at the @ISHLT meeting. We are deeply grateful that @ISHLT is setting such a strong focus on improving CHD and ACHD outcomes and helping children and young adults on their journey!